Michael K Stickland
University of Alberta · Professor, Division of Pulmonary Medicine, Department of Medicine; Director, G.F. MacDonald Centre for Lung Health Covenant Health; Scientific Director, Respiratory Health Strategic Clinical Network, Alberta Health Services
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael K Stickland as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07924007 · Cardiopulmonary Complications of Electronic CigarettesUniversity of Alberta · not yet recruiting · Electronic Cigarette Use, Cannabis Use · principal investigator
- N/ANCT07897357 · Trained vs. Untrained: Lower Extremity Pressure ChangesUniversity of Alberta · recruiting · Trained Athletes, Untrained · principal investigator
- N/ANCT06077994 · Enhanced Pulmonary Rehabilitation With Digital Remote Home MonitoringUniversity of Alberta · completed · Chronic Obstructive Pulmonary Disease · principal investigator
- Ph1NCT06027606 · Cardiovascular Consequences of Inhaled Short-acting Beta-agonist UseUniversity of Alberta · completed · Healthy · principal investigator
- Ph2NCT05061368 · Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPDUniversity of Alberta · recruiting · Chronic Obstructive Pulmonary Disease · principal investigator
- Ph2NCT04985929 · The Impact of Sildenafil on the Pulmonary Circulation in Healthy Trained and Untrained HumansUniversity of Alberta · completed · Healthy · principal investigator
- N/ANCT04732663 · Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19University of Alberta · completed · Covid19, Dyspnea · principal investigator
- N/ANCT03679299 · Vascular Implications of a Naturally Occurring Asthma ExacerbationUniversity of Alberta · terminated · Asthma, Inflammation, Cardiovascular Risk Factor · principal investigator
- Ph1/Ph2NCT03679312 · The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPDUniversity of Alberta · completed · Dyspnea · principal investigator
- N/ANCT03358771 · COPD Discharge Bundle Delivered Alone or Enhanced Through a Care CoordinatorUniversity of Alberta · completed · Pulmonary Disease, Chronic Obstructive · principal investigator
- N/ANCT02965963 · The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During ExerciseUniversity of Alberta · completed · Health · principal investigator
- N/ANCT02917915 · The CaNadian Standardized Pulmonary Rehabilitation Efficacy TrialUniversity of Alberta · completed · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
- N/ANCT02630511 · Asthma Exacerbations and Vascular FunctionUniversity of Alberta · completed · Asthma · principal investigator
- N/ANCT02426437 · Examining Pulmonary Rehabilitation on Discharged COPD PatientsUniversity of Alberta · completed · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:27 UTC. The ranking covers the 200 most relevant of 27 PubMed records, and a shared surname and initials can bring in a namesake. All 27 on PubMed
- 82 citationsRCR 3.3
- 62 citationsRCR 2.6
- Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: A randomized-control cross-over trial.J Physiol · 202147 citationsRCR 4.0
- High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.Ann Am Thorac Soc · 201637 citationsRCR 1.8
- 34 citationsRCR 3.4
- Activation of the carotid chemoreflex secondary to muscle metaboreflex stimulation in men.Am J Physiol Regul Integr Comp Physiol · 201431 citationsRCR 1.5
- The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.J Physiol · 201830 citationsRCR 1.8
- Ventilatory responses to prolonged exercise with heavy load carriage.Eur J Appl Physiol · 201628 citationsRCR 2.2
- 21 citationsRCR 2.4
- Peripheral chemoreceptor control of cardiovascular function at rest and during exercise in heart failure patients.J Appl Physiol (1985) · 201520 citationsRCR 1.0